NORWALK, Conn., Oct. 14, 2023 /PRNewswire/ -- LifeSpan Vision Ventures, a venture capital firm dedicated to advancing the field of longevity biotechnology, is proud to announce the closing of its seventh investment, bringing marks another significant step toward its mission of extending life expectancy.
The most recent addition to LifeSpan's portfolio is Rejuvenation Technologies, which uses lipid nanoparticles to deliver telomerase mRNA to restore telomere length and tissue regenerative capacity. This latest partnership underscores LifeSpan's commitment to identifying and supporting companies that are at the forefront of developing cutting-edge solutions to address the challenges of the biology of aging and age-related diseases.
"We are excited to present our seventh investment as we continue to advance the longevity field," said Harry Robb, analyst at LifeSpan Vision Ventures. "Our dedication to extending life expectancy and enabling longer, healthier and more fulfilling lives for all remains at the core of our mission. We believe the companies we invest in will play a critical role in driving the next wave of "biotechnological solutions that promise a brighter future."
LifeSpan Vision Ventures' recent investment in Rejuvenation Technologies is the latest addition to a series of strategic investments, closely following funding rounds for pioneering companies such as LIfT Biosciences, Deciduous Therapeutics and Fauna Bio, with more investments to be announced in the coming weeks.
For more information about LifeSpan Vision Ventures, visit https://www.lifespanvisionventures.com/.
About LifeSpan Vision Ventures
LifeSpan Vision Ventures is a forward-thinking venture capital firm specializing in investments within the aging and longevity space. Our mission is to support and accelerate the development of innovative therapies that extend life expectancy, improve people's quality of life as they age, and address age-related challenges. Through strategic partnerships and investments, we aim to shape a future where aging is met with vitality, resilience and infinite possibilities.
Contact: Harry RobbMobile: 44 7795042764harry.robb@lifespanvision.com
Photo - https://mma.prnewswire.com/media/2247122...
View original content: https://www.prnewswire.com/news-releases/lifespan-vision-ventures-realiza-su-septima-inversion-a-favor-de-la-mision-de-longevidad-301956795.html
